RALLIS

0 RALLIS INDIA LIMITED corporate ldentity No. 136992MH1948P1C014083 2ndFloor ShardaTerraces Plot No 65 Sectorll CEDBelapur NaviMumbai4O0 614 Iel 91 22 6776 1651 Fax 91 22 6776 1775 email yash.sheth@rallis.co.in Yash Shcth Company Secretary 18th July, 2019 The General Manager Asst. Vice President Corporate Relationship Dept. National Stock Exchange of lndia Ltd. BSE Limited Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G Block Dalal Street Bandra - Kurla Complex, Bandra (E) Mumbai 400 001 Mumbai 400 051 Fax No.2272 2039 I 2272 2O4L Fax No. 2659 8237 I 2559 8238 Scrip Code: 500355 Symbol: RALLIS Dear Sir, Sub: lnvestor Presentation. With regard to the Conference Call scheduled on 19th July,2019 and pursuant to Regulation 30 read with Schedule lll Part A Para A of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we are enclosing the lnvestor presentation to be made at the aforesaid conference for your reference and records. Thanking you, Yours faithfu lly, RALLIS INDIA LIMITED (YASH SHETH) Regd Office 156/157 lsth Floor Nariman Bhavan 227 Nariman Point Mumbai/too 021 Encl: a/a rel gr 22 6t6s 27oo Fax 9122 6665 28/7 website wwwralliscoin IAIA A EnterPrise Results Presentation Q1 FY20 1 Copyright © Rallis India Limited. All rights reserved. Disclaimer This presentation,exceptfor thehistoricalinformation,may contain statements,including the wordsorphrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variations of these expressions or negatives of these terms indicating future performance or results, financial or otherwise of Rallis India Limited, its direct and indirect subsidiaries and its associates. Actual results might differ substantially or materially from those expressed or implied. Important factors that could make a difference to the Company’s operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas markets in which the Company operates, changes in Government policies and regulations, tax laws, and other statutes and incidental factors. You are urged to view all statements contained herein with caution. Rallis India Limited does not undertake any obligation to update or revise forward look statements, whether as a result of new information, future events orotherwise. 2 Copyright © Rallis India Limited. All rights reserved. Rallis – Areas of Strength Well entrenched connect Chemistry with the Indian farmer ) ) s • Crop Protection s • Partnering with global s s e e n n i i innovators s • Plant Growth Nutrients s u u b b c i (PGN) l a • Strong R&D & executional t n s e o m i t capabilities • Soil conditioners a o n D r ( e • Environmentally adhering • Seeds t n I ( products Proven capabilities make Rallis a Preferred Partner of Choice forInnovators 3 Copyright © Rallis India Limited. All rights reserved. Domestic business Leading Agrochemical Company Presence across value chain: Seeds ––– Soil conditioners– Crop Protection Chemicals-Plant growth nutrients Market share: ~ 6% (Crop protection & PGN), ~3% (Seeds) Strong & Healthy pipeline of sustainable products Nation wide footprint – 3,500 dealers & 40000+ retailers 4 Copyright © Rallis India Limited. All rights reserved. International Business – Primed for growth Alliances Contract Manufacturing • Developing Technical for global Agro chemicalsplayers • Developing molecules for global -Agro chemicalplayers • Keyproducts • Key products -Poly Ether Ketone Ketone (PEKK) &Metconazole – Pendimethalin:Usedasa pre-emergence herbicide to control annual grasses and certain broad leaved weeds. Global • Poly Ether Ketone Ketone(PEKK) marketsize:413MnUSD – Major supplier of PEKK forSolvay –Acephate: Anorganophosphate foliarandsoilinsecticide used FACTS primarily for control of aphids, leaf miners, caterpillars, • Polyetheretherketone (PEKK) is a sawflies,thrips,andspidermites.Globalmarketsize:510Mn high-performance, engineering USD thermoplastic characterized by an 1st Indian company unusual combination of properties - –Hexaconazole:isa Broad-spectrumsystemictriazole fungicide to introduce a new resistance to chemicals, wear, usedforthecontrolofmanyfungiparticularly Ascomycetes fatigue moleculeinIndia and Basidiomycetes, used chiefly for the control of rice sheathblightinChina,India,Vietnamand partsofEastAsia. • PEKK and its composites are widely 1st company to set GlobalMarketsize:149MnUSD used in aerospace, automotive, up an R&D centre in structural, high temperature – Metribuzin: herbicide used both pre- and post-emergence in thecountry electrical and biomedical crops including soy bean, potatoes, tomatoes and sugar applications cane.Globalmarketsize:196MnUSD • Metconazole – Metalaxyl: an acylalanine fungicide used to control Pythium in a number of vegetable crops, and Phytophthora in peas, – Fungicide supplied to Kureha Chemicals, a Global market size: 89 MnUSD leader in specialitychemicals Source: Kleffmann market researchFY17-18 Opportunity Size: Agrochemicals products worth US$ 2.9 bn expected to go off patent between 2017 -20 5 Copyright © Rallis India Limited. All rights reserved. Seed business Metahelix develops, produces and sells hybrid seeds including Paddy, Millet, Maize and Bt Cotton with main exposure (80-85%)to theKharif season Strong market position - among top 3 in Hybrid Paddy(3rd) & Hybrid Millet (3rd) and Maize (6th). With over a million packets sold, our Bt Cotton portfolio is fastgrowing Farmer base of 3 Mn up from1 Mn inFY15 Seasonal business – Q1 & Q2 accounting for 85% of revenues The Board approved the merger of Metahelix (a wholly owned subsidiary of the Company) with the Company under a Scheme of Amalgamation subject to necessary statutory approvals from various regulatory authorities 6 Copyright © Rallis India Limited. All rights reserved. Strategic Initiatives Domestic business: • Refreshing distribution channel : Adding distributors to enhance growth • Revitalized channel policies • Increase focus on new product launches • Improve connect between distributors and Company International business: • Investing in capacity expansion • Registration in Internationalmarkets • Expand foot prints in South East Asian countriesand Africa 7 Copyright © Rallis India Limited. All rights reserved. Q1 FY20 - Performance Highlights  Revenue growth of 8.8% for the quarter over PY largely driven by International business and Seed business (Seasonally strong quarter)  International business delivered growth of 12% and contributed 39% share in Standalone revenue  Seed business growth of 2.6% primarily driven by Bajra, Maize & Cotton  Domestic Crop Protection Chemicals business remained soft due to challenging conditions  PAT for the quarter stood at Rs. 67.57 crore higher by 23.8%  Completed first stage expansion of Metribuzin 500 metric tons in June 2019; commercial production started. 8 Copyright © Rallis India Limited. All rights reserved. Seed business - Performance Robust performance in a seasonally strong quarter  Performance largely driven by Paddy, Maize and BT cotton  Cotton & Maize combined contributed 83% of the overall sales  Good traction for Millet new hybrids MP 7171 & MP 7878 @470 MT (PY ~100 MT). Moderate impact of short supplies  Sowing area witnessed double digit decline during the quarter  Undertaking efforts towards building a complete and a robust portfolio – plan to expand into Rabi through alliances 9 Copyright © Rallis India Limited. All rights reserved. Capex - Update  Capex of Rs. 800 crore over FY19-24/25 for strengthening domestic & International business; build product pipeline; streamline supply chain  Scaling up capacities of selective molecules -  Completed first stage capacity expansion of Metribuzin 500 MT in June 2019 and initiated commercial production  Phase II – Addition of 500 tons to be completed by December 2020  Commencement of commercial operations of the above projects coupled with efforts towards ramping up utilization in Pendimethalin to support International Business  Capex for backward Integration: Plan to invest Rs 140 crore into backward integration for few of the technical 10 Copyright © Rallis India Limited. All rights reserved. Operational Highlights  The company received NABL certification for its R & D unit at Bengaluru  It also received registration certificate of 2 products- Zygant (Flubendiamide 0.7% GR) & Ayaan (Kresoxim-methyl 40% + Hexaconazole 8% WG)- Launch planned in July 2019 Widening footprint  New Channel policy announced earlier in the quarter is well accepted by the channel.  Expansion of channel network is an ongoing process 11 Copyright © Rallis India Limited. All rights reserved. Consolidated Financials Rs. crs 700 16.0% 15.2% 623.24 14.5% 600 573.11 14.0% 12.0% 500 10.8% 10.0% 9.5% 400 8.0% 300 6.0% 200 4.0% 94.78 83.14 100 67.57 54.58 2.0% 0 0.0% Q1 FY 19 Q1 FY 20 Revenue EBIDTA PAT EBIDTA % PAT % 12 Copyright © Rallis India Limited. All rights reserved. Contact Us For further information, please contact: Ashish Mehta Chief Financial Officer, Rallis India Ltd Phone : +91 22 6665 2950 Email:ashishmehta@rallis.co.in Gavin Desa / Suraj Digawalekar CDR, India Phone : +91 22 6645 1237 / 1219 Email: gavin@cdr-india.com / suraj@cdr-india.com 13 Copyright © Rallis India Limited. All rights reserved. END OF DOCUMENT 14 Copyright © Rallis India Limited. All rights reserved.